{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:07:19Z","timestamp":1780412839833,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.clinthera.2010.03.020","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T08:57:25Z","timestamp":1272617845000},"page":"678-690","source":"Crossref","is-referenced-by-count":10,"title":["Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily"],"prefix":"10.1016","volume":"32","author":[{"given":"Sebastian","family":"Haag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.03.020_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: A global evidencebased consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2010.03.020_bib2","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1097\/MCG.0b013e318033dfa2","article-title":"Global clinical symptom spectrum in gastroesophageal reflux disease","volume":"41","author":"M\u00f6nnikes","year":"2007","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.03.020_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000101084","article-title":"Novel measurement of rapid treatment success with ReQuest: First and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole","volume":"75","author":"M\u00f6nnikes","year":"2007","journal-title":"Digestion"},{"key":"10.1016\/j.clinthera.2010.03.020_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006036.pub2","article-title":"Medical treatments in the short term management of reflux oesophagitis","volume":"2","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2010.03.020_bib5","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","article-title":"Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study","volume":"98","author":"Miner","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2010.03.020_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/003655298750026886","article-title":"Time to relief of episodic symptoms of gastro-oesophageal reflux disease. A crossover comparison of single doses of the effervescent and standard formulations of ranitidine","volume":"33","author":"Elm","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinthera.2010.03.020_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0149-2918(97)80074-4","article-title":"On-demand therapy in gastroesophageal reflux disease: A comparison of the early effects of single doses of fast-dissolving famotidine wafers and ranitidine tablets","volume":"19","author":"Johannessen","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2010.03.020_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2036.2006.03129.x","article-title":"Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment","volume":"25","author":"Miner","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2010.03.020_bib9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1046\/j.1365-2036.2002.01366.x","article-title":"Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: A randomized, active-controlled, double-blind study","volume":"16","author":"Kovacs","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2010.03.020_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000051885","article-title":"Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease","volume":"63","author":"Kaspari","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.clinthera.2010.03.020_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2010.03.020_bib12","series-title":"The Esophagus Textbook and Endoscopic Atlas [in German]","author":"Savary","year":"1977"},{"key":"10.1016\/j.clinthera.2010.03.020_bib15","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.155.20.2165","article-title":"Guidelines for the diagnosis and treatment of gastroesophageal reflux disease","volume":"155","author":"DeVault","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2010.03.020_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2005-857870","article-title":"Consensus conference of the DGVS on gastroesophageal reflux [in German]","volume":"43","author":"Koop","year":"2005","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.clinthera.2010.03.020_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000235953","article-title":"Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines","volume":"80","author":"Haag","year":"2009","journal-title":"Digestion"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2010.03.020_bib18","first-page":"A530","article-title":"Pantoprazole 40 mg is comparable to esomeprazole 40 mg for first and sustained symptom relief in patients with erosive gastroesophageal reflux disease (GERD)","volume":"128","author":"van Rensburg","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2010.03.020_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0009922806292792","article-title":"Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD)","volume":"45","author":"Tsou","year":"2006","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.clinthera.2010.03.020_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.mpg.0000214160.37574.d3","article-title":"Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease","volume":"42","author":"Tolia","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2010.03.020_bib21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1365-2036.2003.01593.x","article-title":"Short- and long-term therapy for reflux oesophagitis in the elderly: A multicentre, placebo-controlled study with pantoprazole","volume":"17","author":"Pilotto","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2010.03.020_bib22","first-page":"243","article-title":"Lack of pantoprazole drug interactions in man: An updated review","volume":"34","author":"Steinijans","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2010.03.020_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003495-200363010-00006","article-title":"Pantoprazole: An update of its pharmacological proper ties and therapeutic use in the management of acid-related disorders","volume":"63","author":"Cheer","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2010.03.020_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005176-200302000-00019","article-title":"Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children","volume":"36","author":"Madrazo-de la Garza","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2010.03.020_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00002018-200629090-00002","article-title":"Pharmacokinetic drug interaction profiles of proton pump inhibitors","volume":"29","author":"Blume","year":"2006","journal-title":"Drug Saf"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2010.03.020_bib26","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/ajhp\/56.suppl_4.S11","article-title":"Safety profile ofthe protonpump inhibitors","volume":"56","author":"Rellly","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2010.03.020_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:33:53Z","timestamp":1559079233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0149291810001244"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.03.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}